Stocks
BioXcel (BTAI) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 18 353% | 11 844% | 65 640% | 65 640% | 421 630% | ||||
| Changes by years, y/y, % | +15 388pp | -6 508pp | +53 795pp | 0pp | +355 990pp | +150.4% | |||
BioXcel. R&D/CAPEX, %
BioXcel. R&D/CAPEX, changes, pp
BioXcel (BTAI) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | LTM ? | |||
| R&D/CAPEX, % | 94 242% | 134 865% | ||||||
| Changes by years, y/y, % | +80 733pp | -70 194pp | -104 375pp | -15 466pp | +40 623pp | |||
| Changes by quarters, q/q, % | +78 776pp | -94 242pp | ||||||
